Navigation Links
Improved governance needed to realize nanotech's benefits
Date:4/23/2008

WASHINGTON - Without an improved governance structure, the benefits of nanotechnology may be difficult to fully realize because the public will not trust the cutting-edge technology, says David Rejeski, director of the Project on Emerging Nanotechnologies (PEN). Rejeski testifies on Thursday, April 24, before the Senate subcommittee on technology and innovation.

Public trust is the dark horse in nanotechnologys future, states Rejeski in his testimony. If government and industry do not work to build public confidence in nanotechnology, consumers may reach for the No-Nano label in the future and investors will put their money elsewhere. Public perceptions about risksreal and perceivedcan have large economic impacts. For example, the European Unions ban on genetically modified foods, driven largely by public concerns, cost American farmers an estimated $300 million annually in lost sales and much more in products that never made it to the marketplace.

Congressional lawmakers are currently discussing amendments to and reauthorization of the 21st Century Nanotechnology Research & Development Act, which helps sets the roadmap for the annual $1.5 billion federal spending on nanotechnology research that is vital to ensuring the technologys success.

What: Senate Commerce, Science & Transportation Committee Subcommittee on Science, Technology and Innovation hearing National Nanotechnology Initiative: Charting the Course for Reauthorization

When: April 24, 2008, 2:30 p.m.

Where: Russell Senate Office Building Room 253, Washington, DC

Who: David Rejeski directs the Project on Emerging Nanotechnologies. For the past eight years, he has also been the Director of the Foresight and Governance Project at the Woodrow Wilson Center. He has held various positions at the White House Council on Environmental Quality (CEQ), the White House Office of Science and Technology (OSTP), and the Environmental Protection Agency (EPA). He sits on the advisory boards of a number of organizations, including EPAs Science Advisory Board. He has graduate degrees in public administration and environmental design from Harvard and Yale.


'/>"/>

Contact: Alex Parlini
alex.parlini@wilsoncenter.org
301-768-8366
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology technology :

1. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
2. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
3. Diagnostic Turnaround Improved by 600% Through Interoperability
4. Improved wettability of carbon nanotubes opens the door to new possibilities
5. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
6. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
7. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
8. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
9. Farmers Across the U.S. Realize Double-Digit Yield Advantage From DEKALB(R) Corn Seeds With Triple-Stacked Traits
10. Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage
11. Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):